Semble Raises $40.5M to Transform Outpatient Care

Jan de Vries · 2026-06-04

London-based HealthTech startup Semble just closed a massive Series C round -- $40.5 million (about 34.7 million euros) -- to help outpatient providers finally get their act together. And honestly? The healthcare world could use a shake-up. ### What's the Big Deal? The funding was led by European growth investor Revaia, with help from Partech (a new backer) and continued support from existing investors Mercia Ventures and Octopus Ventures. That's a pretty impressive group, and it shows how much confidence the market has in Semble's approach. Morgan Kessous, a partner at Revaia, put it this way: "Semble is building the system of action for modern healthcare -- a platform with genuine clinical depth, real scale, and the trust of healthcare providers across the UK and France." He's not wrong. The European healthcare market is being reshaped by technology, demand, and shifting patient expectations. And Semble seems perfectly positioned to lead that charge.  ### A Quick Backstory Semble started in 2018 under the name Heydoc, founded by Christoph Lippuner and Mikael Landau. They rebranded in July 2022, but the mission hasn't changed: fix the lack of coordination in healthcare. The platform connects and orchestrates every stage of the patient journey, helping solo clinicians, growing group practices, and complex enterprise organizations deliver faster, safer, and more patient-centered care.  ### Why Now? Healthcare providers across the UK and Europe are drowning in operational pressure. Fragmented technology systems are a nightmare. Patient demand is rising. And there's a generational shift toward private medical insurance and self-pay care models. Semble's platform is designed to cut through that chaos. Christoph Lippuner, CEO and co-founder, explained it well: "For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients." He added: "What healthcare organizations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end." ### What Makes Semble Different? The platform is open and interoperable by design. It integrates with over 1,200 tools across diagnostics, billing, labs, CRM, and more. That's huge. Instead of forcing providers into a single ecosystem, Semble works with what they already have. - Over 10 million patients have received care through the platform - 1,700 customers, including big names like Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality, and ProblemShared - Headcount has jumped over 50% since December 2024 ### What's Next? With this fresh funding, Semble plans to expand into leading healthcare groups, strengthen its position as the AI orchestration layer in modern care delivery, and establish itself in France. The company's flexible platform achieved regulatory maturity there in under a year -- a serious accomplishment. ### The Bottom Line Semble isn't just another HealthTech startup. It's building the infrastructure for how outpatient care should work in the 21st century. And with $40.5 million in the bank, it has the fuel to make that vision a reality. (Note: This article contains nofollow links where applicable.)